Evidence map›Paper›PMID 23066013›Full record

ArticleThe Journal of biological chemistry2012

Direct binding and regulation of RhoA protein by cyclic GMP-dependent protein kinase Iα.

Mikio Kato, Robert Blanton, Guang-Rong Wang, Timothy J Judson, Yuich Abe, Masafumi Myoishi, Richard H Karas, Michael E Mendelsohn

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. CO and NO Coordinate Developmental Neuron Migration.International journal of molecular sciences · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Mikio KatoMolecular Cardiology Research Institute, Tufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts 02111, USA.
Robert Blanton
Guang-Rong Wang
Timothy J Judson
Yuich Abe
Masafumi Myoishi
Richard H Karas
Michael E Mendelsohn
Tufts Medical Center · USTufts University · US

Funding

NITRIC OXIDE SIGNALING MECHANISMS IN VASCULAR CELLSR01HL055309 · NHLBI · TUFTS MEDICAL CENTER · PI KARAS, RICHARD H · 1996 to 2009
$3.0M
Cardiac Myocyte-Specific Role of PKG I Alpha in Aging-Dependent Cardiac RemodelinR03AG042367 · NIA · TUFTS MEDICAL CENTER · PI BLANTON, ROBERT MORRIS · 2012 to 2013
$155k
NHLBI NIH HHS HL55309NHLBI NIH HHS R01 HL055309NIA NIH HHS R03 AG042367
6 · The paper itself

Abstract

Vascular smooth muscle cell (VSMC) tone is regulated by the state of myosin light chain (MLC) phosphorylation, which is in turn regulated by the balance between MLC kinase and MLC phosphatase (MLCP) activities. RhoA activates Rho kinase, which phosphorylates the regulatory subunit of MLC phosphatase, thereby inhibiting MLC phosphatase activity and increasing contraction and vascular tone. Nitric oxide is an important mediator of VSMC relaxation and vasodilation, which acts by increasing cyclic GMP (cGMP) levels in VSMC, thereby activating cGMP-dependent protein kinase Iα (PKGIα). PKGI is known to phosphorylate Rho kinase, preventing Rho-mediated inhibition of MLC phosphatase, promoting vasorelaxation, although the molecular mechanisms that mediate this are unclear. Here we identify RhoA as a target of activated PKGIα and show further that PKGIα binds directly to RhoA, inhibiting its activation and translocation. In protein pulldown and immunoprecipitation experiments, binding of RhoA and PKGIα was demonstrated via a direct interaction between the amino terminus of RhoA (residues 1-44), containing the switch I domain of RhoA, and the amino terminus of PKGIα (residues 1-59), which includes a leucine zipper heptad repeat motif. Affinity assays using cGMP-immobilized agarose showed that only activated PKGIα binds RhoA, and a leucine zipper mutant PKGIα was unable to bind RhoA even if activated. Furthermore, a catalytically inactive mutant of PKGIα bound RhoA but did not prevent RhoA activation and translocation. Collectively, these results support that RhoA is a PKGIα target and that direct binding of activated PKGIα to RhoA is central to cGMP-mediated inhibition of the VSMC Rho kinase contractile pathway.

Indexed as

Gene Expression Regulation3T3 CellsAmino Acid MotifsAnimalsAortaChlorocebus aethiopsCOS CellsCyclic GMP-Dependent Protein Kinase Type IEndothelial CellsHumansHypertensionMiceModels, BiologicalProtein BindingrhoA GTP-Binding Proteinrho-Associated KinasesCyclic GMP-Dependent Protein Kinase Type IrhoA GTP-Binding ProteinRHOA protein, humanRhoA protein, mouserho-Associated Kinasesrho GTP-Binding ProteinsROCK1 protein, humanRock1 protein, mouse

Identifiers

PMID23066013
PMCPMC3510832
OpenAlexW1576177409

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.